FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.10 | FHIR Version n/a User: [n/a]

39697211000001105: Lapatinib 250mg tablets (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Lapatinib 250mg tablets
\UK product\Virtual therapeutic moiety\Lapatinib\Lapatinib 250mg tablets

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1815851000001117 Lapatinib 250mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1815861000001119 Lapatinib 250mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lapatinib 250mg tablets	Is a	Lapatinib	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Is a	Product containing lapatinib	false	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has specific active ingredient	Lapatinib ditosylate monohydrate	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Lapatinib	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lapatinib 250mg tablets 105 tablet	Has VMP	True	Lapatinib 250mg tablets	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets 70 tablet	Has VMP	True	Lapatinib 250mg tablets	Inferred relationship	Existential restriction modifier
Lapatinib 250mg tablets 84 tablet	Has VMP	True	Lapatinib 250mg tablets	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	True	Lapatinib 250mg tablets	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1815851000001117	Lapatinib 250mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1815861000001119	Lapatinib 250mg tablets (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module